Close Menu

sequencing-based diagnostics

NEW YORK (GenomeWeb News) – Pathogenica said today that it will co-market with Illumina a new version of its HAI BioDetection kit on Illumina's MiSeq desktop sequencing system in the Asia Pacific region.

NEW YORK (GenomeWeb News) – Life Technologies today said that it has inked a companion diagnostics deal with pharmaceutical firm Merck Serono for an undisclosed oncology target and eventually other therapeutic areas.

NEW YORK (GenomeWeb News) – MDx Health and HistoGeneX today announced a collaboration to provide molecular diagnostic testing services to drug manufacturers and oncologists.

NEW YORK (GenomeWeb News) — PathoQuest, an infectious disease diagnostics startup based in Paris, has raised €3.8 million ($5 million) in a Series B private equity funding round, the company said today.

NEW YORK (GenomeWeb News) – Two hospitals in the Netherlands — the University Medical Center Groningen and Amphia Hospital — plan to evaluate and adopt Pathogenica's next-generation sequencing-based HAI BioDetection Kit in the surveillance and monitoring of infectious bacteria, the company said t

NEW YORK (GenomeWeb News) – Myriad Genetics and others have fired off another salvo against a company that began offering BRCA1 and BRCA2 testing following the US Supreme Court's decision last month

NEW YORK (GenomeWeb News) – Sequenta has completed a Series C financing round, raising $20 million, it said on Tuesday.

NEW YORK (GenomeWeb News) – Case Western Reserve University said today that it has licensed exclusive worldwide rights to University Hospitals Case Medical Center to a series of HIV diagnostic tests.

NEW YORK (GenomeWeb News) – Illumina said today that its noninvasive prenatal testing subsidiary Verinata Health has signed an exclusive agreement with Teva Pharmaceutical Industries to commercialize its Verifi test in Israel.

Following the US Supreme Court's decision two weeks ago to strike down Myriad Genetics' central patent claims to the BRCA1 and BRCA2 genes, several US genetic testing laboratories have been gearing up to snatch a piece of the BRCA testing market in this country, previously Myriad

Pages

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.